SCHEMBL19250331

SCHEMBL19250331

C[C@@]1(C(=O)OCI)CCCC[C@H]1N

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.32
ABCB11 O95342 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CYP2D6 P10635 1/20 0.32
CHRM1 P11229 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CHRM3 P20309 1/20 0.32
DRD1 P21728 1/20 0.32
HRH2 P25021 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32
SCN1A P35498 1/20 0.32
THPO P40225 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27639337 0.80 MAPT (0.41) CYP3A4MEN1MAPK1KMT2ANPSR1
Hydrochloric Acid SCHEMBL5528439 0.78 MAPT (0.41) CYP3A4MEN1MAPK1KMT2ANPSR1
SCHEMBL2201143 0.75 NR1H2 (0.34) CYP3A4ABCB11LMNACYP1A2CHRM2
SCHEMBL27558383 0.75 GAA (0.32)
SCHEMBL2124178 0.73 FFAR3 (0.36) LMNACYP2C9THPOF10MAPK1
SCHEMBL2124898 0.73 FFAR3 (0.36) LMNACYP2C9THPOF10MAPK1
SCHEMBL17784260 0.73 FFAR3 (0.36) LMNACYP2C9THPOF10MAPK1
SCHEMBL9970858 0.73 FFAR3 (0.36) LMNACYP2C9THPOF10MAPK1
SCHEMBL2124177 0.73 FFAR3 (0.36) LMNACYP2C9THPOF10MAPK1
SCHEMBL10303638 0.73 FFAR3 (0.36) LMNACYP2C9THPOF10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133667-A1 PYRIMIDINE AND PYRIDINE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed